Positron Corporation is a medical technology company that co-develops, manufactures, and sells PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. The company combines proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, and a focus on…
Positron Corporation is a medical technology company that co-develops, manufactures, and sells PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. The company combines proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, and a focus on operational efficiency to make advanced diagnostic imaging more accessible and sustainable for hospitals, outpatient centers, and physician practices. Positron specializes in cardiac PET imaging and maintains a growing presence in oncology and neurology, positioning it at the forefront of innovation in nuclear medicine.
Positron generates revenue primarily through the sale of its PET and PET-CT imaging systems, along with associated clinical, training, and technical support services. The company offers flexible commercial arrangements, including rental and service agreements structured as multi-year contracts, to align with the operational and financial requirements of healthcare providers. As of the filing date, substantially all historical revenues have been derived from PET system services, though the company has received deposits for its upcoming Affinity™ PET-CT 4D 64-slice system.
Positron Corporation operates through the following segments:
- PET and PET-CT Molecular Imaging Systems: This segment encompasses the design, development, manufacturing, and commercialization of dedicated PET systems and next-generation PET-CT platforms, including the Affinity™ PET-CT 4D system intended to support cardiology, oncology, and neurology applications. Positron markets these systems under trademarked names such as Positron®, Attrius®, and Affinity PET-CT™. The company focuses on delivering cost-effective imaging solutions optimized for cardiovascular applications while expanding capabilities into multi-disciplinary imaging through its strategic collaboration with Neusoft Medical Systems.
- Clinical, Training, and Technical Support Services: This segment provides comprehensive support to ensure system performance, reliability, and utilization, including physician and technologist training, billing and prior-authorization assistance, clinical over-read support, and ongoing technical guidance. Positron offers continuous support coverage, including 24/7 technical assistance, priority response, and after-hours service availability, along with software updates and system enhancements. The company maintains a team of field service engineers responsible for installation, maintenance, hardware upgrades, and service contract fulfillment, with internal data indicating average system uptime in excess of 98%.
Positron Corporation operates in a competitive nuclear imaging equipment market dominated by large multinational original equipment manufacturers such as GE HealthCare, Philips Healthcare, and Siemens Healthineers. The company differentiates itself through its focused expertise in cardiac PET and PET-CT imaging, proprietary imaging systems optimized for cardiovascular applications, and an integrated service and support model designed to reduce implementation barriers. Positron targets mid-sized hospitals and outpatient imaging centers that may be underserved by larger competitors, leveraging its cost-effective pricing strategy and flexible financing options to gain market share in the ongoing transition from SPECT to PET-CT imaging.
Positron serves healthcare providers including hospitals, outpatient imaging centers, and cardiology practices across the United States. The company benefits from an established customer base and long-standing relationships with referring physicians and imaging facilities, which support repeat business and customer referrals. Its solutions are designed to meet the needs of nuclear cardiologists and other medical professionals seeking to improve diagnostic accuracy, workflow efficiency, and patient care through advanced molecular imaging technology.